Top Selling MG217 products 

MG217 are products designed to treat eczema and psoriasis.  Their products bring relief to 7.5 million Americans.  Available now for sale and delivered in Metro Manila.

Block "14938" not found

Statistics about Psoriasis

Eczema (atopic dermatitis) is caused by a combination of immune system activation, genetics, environmental triggers and stress. Your immune system. If you have eczema, your immune system overreacts to small irritants or allergens. This overreaction can inflame your skin.

Psoriasis is a chronic, autoimmune disease that appears on the skin. Psoriasis occurs when skin cells quickly rise from their origin below the surface of the skin and pile up on the surface before they have a chance to mature. This happens because the immune system sends out faulty signals that speed up the growth cycle of the skin cells. Normally this turnover takes about a month, but in psoriasis it may occur in only a few days.


  • Psoriasis is the most prevalent autoimmune disease in the United States.
  • According to current studies, as many as 7.5 million Americans – approximately
    2.2% of the population – have psoriasis.
  • 125 million people worldwide – 2% to 3% of the total population – have psoriasis, according to the World Psoriasis Day consortium.
  • Studies show that between 10% and 30% of people with psoriasis also develop psoriatic arthritis.
  • Psoriasis prevalence in African Americans is 1.3% compared to 2.5% of Caucasians.

Quality of Life

  • Nearly 60% of people with psoriasis reported their disease to be a large problem in their everyday life.
  • Nearly 40% with psoriatic arthritis reported their disease to be a large problem in everyday life.
  • Patients with moderate to severe psoriasis experienced a greater negative impact on their quality of life.
  • Psoriasis has a greater impact on quality of life in women and younger patients.

Age of Onset

  • Psoriasis often appears between the ages of 15 and 25, but can develop at any age.
  • Psoriatic arthritis usually develops between the ages of 30 and 50, but can develop at any age.

Severity of Psoriasis

  • The National Psoriasis Foundation defines mild psoriasis as affecting less than 3% of the body; 3% to 10% is considered moderate; more than 10% is considered severe. For most individuals, your hand is about the same as 1% of the skin surface. However, the severity of psoriasis is also measured by how psoriasis affects a person’s quality of life.
  • Nearly one-quarter of people with psoriasis have cases that are considered moderate to severe.

Cost of Psoriasis

  • Total direct and indirect healthcare costs of psoriasis for patients are calculated at $11.25 billion annually, with work loss accounting for 40% of the cost burden.
  • Approximately 60% of psoriasis patients missed an average of 26 days of work a year due to their illness.

Genetic Aspects of Psoriasis

  • About one out of three people with psoriasis report having a relative with psoriasis.
  • If one parent has psoriasis, a child has about a 10% chance of having psoriasis. If both parents have psoriasis, a child has approximately a 50% chance of developing the disease.